Literature DB >> 18131595

Chloromycetin in experimental rickettsial infections.

J E SMADEL, E B JACKSON, A B CRUISE.   

Abstract

Entities:  

Keywords:  CHLOROMYCETIN; INFLUENZA/immunity; RICKETTSIAL DISEASES/therapy

Mesh：

Substances：

Year:  1949        PMID： 18131595

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

1.  Susceptibility of Rickettsia rickettsii to Tigecycline in a Cell Culture Assay and Animal Model for Rocky Mountain Spotted Fever.

Authors:  Lucas S Blanton; Nicholas M Wilson; Bethany R Quade; David H Walker
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

Review 2.  Antibiotic treatment of rickettsiosis, recent advances and current concepts.

Authors:  D Raoult
Journal:  Eur J Epidemiol       Date:  1991-05       Impact factor: 8.082

3.  Persistence of Orientia tsutsugamushi in humans.

Authors:  Moon-Hyun Chung; Jin-Soo Lee; Ji-hyeon Baek; Mijeong Kim; Jae-Seung Kang
Journal:  J Korean Med Sci       Date:  2012-02-23       Impact factor: 2.153

Review 4.  Buerger's Disease May be a Chronic Rickettsial Infection with Superimposed Thrombosis: Literature Review and Efficacy of Doxycycline in Three Patients.

Authors:  Moon-Hyun Chung; Jin-Soo Lee; Jae-Seung Kang
Journal:  Infect Chemother       Date:  2022-03

5.  In vitro bacteriostatic effects of rifampin on Orientia tsutsugamushi.

Authors:  Jae-Hyoung Im; Ji Hyeon Baek; Jin-Soo Lee; Moon-Hyun Chung; Sun Myoung Lee; Jae-Seung Kang
Journal:  J Korean Med Sci       Date:  2014-01-28       Impact factor: 2.153

Review 6.  The Historical Case for and the Future Study of Antibiotic-Resistant Scrub Typhus.

Authors:  Daryl J Kelly; Paul A Fuerst; Allen L Richards
Journal:  Trop Med Infect Dis       Date:  2017-12-15

Review 7.  Origins, Importance and Genetic Stability of the Prototype Strains Gilliam, Karp and Kato of Orientia tsutsugamushi.

Authors:  Daryl J Kelly; Paul A Fuerst; Allen L Richards
Journal:  Trop Med Infect Dis       Date:  2019-04-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.